[1] Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. New Engl J Med, 1995, 332:1463-1466.
[2] Tremolada F, Casarin C, Alberti A, et al. Lon-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol, 1992, 16:273-281.
[3] Thien HH, Yi Q, Dore GJ, et al. Estimation of stage-specific fibrosis progression rate in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology, 2008, 48:418-431.
[4] El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132:2557-2576. |
